close

Fundraisings and IPOs

1 57 58 59 60 61 74
Number of results: 1471
Date Company Amount Funding type Investors Therapeutic area Type of Information
2012-11-05 Kalvista Pharmaceuticals (UK) £2.4 million (€ 3 million) grant Biomedical Catalyst Fund (UK) Ophtalmological diseases Grant
2012-11-05 Immunocore (UK) £2.4 million (€ 3 million) grant Biomedical Catalyst Fund (UK) Cancer - Oncology Grant
2012-11-05 Intelligent Fingerprinting (UK) £425,000 (€ 533 350) grant Biomedical Catalyst Fund (UK) Technology - Services Grant
2012-11-05 Modern Biosciences (UK) £1.6 million (€ 2 million) grant Biomedical Catalyst Fund (UK) Grant
2012-11-05 PsiOxus Therapeutics (UK) £1.7m (€2.1 million) grant Biomedical Catalyst Fund (UK) Cancer - Oncology Grant
2012-11-05 Sentinel Oncology (UK) £1.8m (€ 2.2 million) grant Biomedical Catalyst Fund (UK) Cancer - Oncology Grant
2012-11-04 Discuva (UK) £1.62 million (€ 2 million) grant Biomedical Catalyst Fund (UK) - New Wave Ventures LLP (UK) Infectious diseases Grant
2012-11-02 Dilaforette (Sweden) SEK 2.85 million (€ 0.3 million) grant Vinnova, Swedish Governmental Agency for Innovation Systems (Sweden) Infectious diseases Grant
2012-11-01 ValiRx (UK) £2.03 million (€2.5 million) Cancer - Oncology Fundraising
2012-10-31 Haemostatix (UK) £1.4 million (€1.78 million) + £800,000 award Wellcome Trust (UK)
Albion Ventures (UK)
Catapult Venture Managers (UK)
Spark Ventures (UK)
Esperante (UK)
Nesta (UK)
the Lachesis Fund
The University of Leicester (UK)
private share-holders (UK)
Hemostasis Subvention
2012-10-31 Phenex Pharmaceuticals (Germany) € 5 million EVP Capital Partners (Germany) Autoimmune diseases – Immunological diseases - Liver diseases Fundraising
2012-10-30 Complix (Belgium) € 1.9 Million grant

Flemish agency for Innovation by Science and Technology (IWT) (Belgium)

Cancer - Oncology - CNS diseases - Inflammatory diseases - Metabolic diseases Grant
2012-10-25 AMP Therapeutics (Germany) € 1.7 million grant SAB State Bank of Saxony (Germany) Infectious diseases Grant
2012-10-24 Nanobiotix (France) € 20 million IPO Cancer - Oncology IPO
2012-10-24 Orizon (Spain) € 1.1 million grant Ministry of Economy and Competitiveness (Spain) Cancer - Oncology Grant
2012-10-23 4SC (Germany) € 600,000 grant Cancer - Oncology Grant
2012-10-23 Vaccibody (Norway) €2 million grant Norwegian Research Council (Norway) Cancer - Oncology - Infectious diseases Grant
2012-10-22 Summit (UK) £4.0 million (€4.9 million) award Wellcome Trust (UK) Rare diseases - Neuromuscular diseases - Infectious diseases Subvention
2012-10-22 Pharma Two B (Israel) $8 million financing round Neurodegenerative diseases Fundraising
2012-10-19 Redx Pharma (UK) £4.7 million (€5.7 million) grant Regional Growth Fund (RGF) (UK)
Infectious diseases Grant